Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Lly crawled time : 11:00 save search
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 1.03%
H: 1.66%
C: -1.11%
obesity tirzepatide
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.91 0.0% 0
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | $92.57 -0.55% 0.51% 0
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | News | $13.99 1.23% 1.29% 3.1M
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $10.72 -6.86% -6.87% 43
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
Published: 2024-03-26 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
expansion therapeutics
ProQR Announces Year End 2023 Operating and Financial Results
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
PRQR | $1.86 -2.11% -2.15% 0
|
Health Technology
|
| O: -1.46%
H: 21.78%
C: 15.35%
year financial results
Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor
Published: 2023-12-12 (Crawled : 11:00) - globenewswire.com
ALLR | $1.54 2.67% 11.76% 55K
|
n/a
|
| O: -2.26%
H: 9.41%
C: 7.03%
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
ceo therapeutics
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines
Published: 2023-11-13 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -0.26%
H: 4.11%
C: 3.09%
genetic series
AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Published: 2023-11-03 (Crawled : 11:00) - globenewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
ACIU | $2.38 -1.65% 0.41% 400
|
Health Technology
|
| O: -4.91%
H: 0.0%
C: 0.0%
update financial results
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 4.42%
H: 0.0%
C: 0.0%
ACIU | $2.38 -1.65% 0.41% 400
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: 0.0%
disease alzheimer’s imaging
Lilly Declares Fourth-Quarter 2023 Dividend
Published: 2023-11-01 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
Published: 2023-11-01 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
UTHR | $236.93 0.69% 0.78% 30
|
Health Technology
|
| O: -5.01%
H: 7.34%
C: 5.85%
corporation therapeutics financial results
AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
Published: 2023-10-27 (Crawled : 11:00) - globenewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
ACIU | $2.38 -1.65% 0.41% 400
|
Health Technology
|
| O: -10.03%
H: 0.0%
C: 0.0%
aci-1258 aci-12589 disease alpha-synuclein diagnostic communications neurodegenerative potential show
Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors
Published: 2023-10-25 (Crawled : 11:00) - prnewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 2.75%
H: 0.46%
C: -1.76%
FGEN | $1.17 -7.87% -9.01% 2.1K
|
Health Technology
|
| O: 2.32%
H: 3.75%
C: 0.89%
company
Nearly 80% of patients with moderate-to-severe atopic dermatitis maintained clear or almost clear skin with Lilly's lebrikizumab monthly maintenance dosing at two years
Published: 2023-10-20 (Crawled : 11:00) - prnewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -1.52%
H: 0.0%
C: 0.0%
dermatitis skin
AC Immune Announces Upcoming Presentations at the 16th CTAD Conference
Published: 2023-10-17 (Crawled : 11:00) - globenewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 0.97%
H: 0.23%
C: -1.73%
ACIU | $2.38 -1.65% 0.41% 400
|
Health Technology
|
| O: 1.5%
H: 6.64%
C: 3.32%
conference
Almirall's Lebrikizumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis (AD) in Patients Inadequately Controlled With or Ineligible for Cyclosporine1
Published: 2023-10-13 (Crawled : 11:00) - biospace.com/
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
dermatitis
Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors
Published: 2023-10-11 (Crawled : 11:00) - globenewswire.com
ZYME | $8.67 -2.03% -1.96% 260
|
Health Technology
|
| O: -0.16%
H: 0.93%
C: 0.85%
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 4.47%
H: 2.11%
C: 1.52%
AXSM | $65.72 -5.72% -5.93% 170
|
Health Technology
|
| O: -0.11%
H: 1.04%
C: -0.41%
therapeutics
AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023
Published: 2023-10-05 (Crawled : 11:00) - globenewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
ACIU | $2.38 -1.65% 0.41% 400
|
Health Technology
|
| O: -1.12%
H: 0.0%
C: -6.04%
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
Published: 2023-10-02 (Crawled : 11:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
EBS | $1.86 -2.11% -3.23% 770K
|
Health Technology
|
| O: 0.0%
H: 0.15%
C: -7.06%
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: 0.0%
LQDA M | $13.81 -0.36% -0.36% 250
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -1.74%
Orange Grove Bio Subsidiary Awarded $2.05 Million SBIR Phase II Grant to Advance Development of Novel Platelet Preservation Technology
Published: 2023-09-28 (Crawled : 11:00) - biospace.com/
FNCTF | News | $11.0354 -0.83% -20.84% 0
|
Communications
|
| O: 0.22%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 0.28%
H: 0.07%
C: -1.25%
grant technology
ProQR Therapeutics Provides Update on Ophthalmic Assets
Published: 2023-09-27 (Crawled : 11:00) - globenewswire.com
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: -0.26%
H: 0.33%
C: -0.02%
PRQR | $1.86 -2.11% -2.15% 0
|
Health Technology
|
| O: 0.0%
H: 1.38%
C: -4.83%
update therapeutics
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K
|
EGOX | $0.036 12.15% 31.56% 32M
|
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
TPET | $0.3279 -3.56% 23.57% 11M
|
n/a
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.